We demonstrate that nuclear changes indicative of glioma cell regression are not limited to the direct perivascular region in this combination anymore, supporting improved tumor penetration of TMZ by anti-Ang-2/VEGF-A co-inhibition. This evidence concerns the gene ANGPT2 and glioma.